Abstract Background People who inject drugs (PWID) in Europe are at an increased risk of HIV/AIDS. chronic viral hepatitis B (HBV) and C (HCV). and tuberculosis (TB). We aimed to complement the evidence base on interventions optimising their care cascade with evidence from models of good practice (MoGPs) implemented in the EU/EEA and countries from the Eastern European region. https://www.rawafricaonline.com/